These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 10377955)
1. Effects of some 1,4-dihydropyridine Ca antagonists on the blast transformation of rat spleen lymphocytes. Briede J; Daija D; Bisenieks E; Makarova N; Uldriķis J; Poikans J; Duburs G Cell Biochem Funct; 1999 Jun; 17(2):97-105. PubMed ID: 10377955 [TBL] [Abstract][Full Text] [Related]
2. Effect of new and known 1,4-dihydropyridine derivatives on blood glucose levels in normal and streptozotocin-induced diabetic rats. Briede J; Stivriņa M; Stoldere D; Bisenieks E; Uldriķis J; Poikāns J; Makarova N; Duburs G Cell Biochem Funct; 2004; 22(4):219-24. PubMed ID: 15248181 [TBL] [Abstract][Full Text] [Related]
3. Effect of cerebrocrast on the lymphocyte blast transformation activity in normal and streptozotocin-induced diabetic rats. Briede J; Daija D; Stivrina M; Duburs G Cell Biochem Funct; 1999 Jun; 17(2):89-96. PubMed ID: 10377954 [TBL] [Abstract][Full Text] [Related]
4. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus. Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170 [TBL] [Abstract][Full Text] [Related]
5. Mitogen and co-mitogen stimulation of lymphocytes inhibited by three Ca++ antagonists. Grier CE; Mastro AM J Cell Physiol; 1985 Jul; 124(1):131-6. PubMed ID: 3930516 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of human equilibrative nucleoside transporters by dihydropyridine-type calcium channel antagonists. Li RW; Tse CM; Man RY; Vanhoutte PM; Leung GP Eur J Pharmacol; 2007 Jul; 568(1-3):75-82. PubMed ID: 17512522 [TBL] [Abstract][Full Text] [Related]
7. Acute effect of antidiabetic 1,4-dihydropyridine compound cerebrocrast on cardiac function and glucose metabolism in the isolated, perfused normal rat heart. Briede J; Stivrina M; Vigante B; Stoldere D; Duburs G Cell Biochem Funct; 2008; 26(2):238-45. PubMed ID: 17990288 [TBL] [Abstract][Full Text] [Related]
9. Blocking of human T lymphocyte activation by channel antagonists. Bono MR; Simon V; Rosemblatt MS Cell Biochem Funct; 1989 Jul; 7(3):219-26. PubMed ID: 2477169 [TBL] [Abstract][Full Text] [Related]
10. [Biochemical effects of ryodipine (foridon)--a new calcium antagonist and derivative of 1,4-dihydopyridine]. Simkhovich BZ; Mezhapuke RIa; Dubur GIa Farmakol Toksikol; 1988; 51(3):30-4. PubMed ID: 2842181 [TBL] [Abstract][Full Text] [Related]
11. Comparative effects of three 1,4-dihydropyridine derivatives [OSI-1210, OSI-1211 (etaftoron), and OSI-3802] on rat liver mitochondrial bioenergetics and on the physical properties of membrane lipid bilayers: relevance to the length of the alkoxyl chain in positions 3 and 5 of the DHP ring. Fernandes MA; Pereira SP; Jurado AS; Custódio JB; Santos MS; Moreno AJ; Duburs G; Vicente JA Chem Biol Interact; 2008 Jun; 173(3):195-204. PubMed ID: 18452904 [TBL] [Abstract][Full Text] [Related]
12. Effect of cerebrocrast on the function of human platelets and release of the arachidonic acid from plasma membrane. Briede J; Heidemanis K; Dabina I; Duburs G Cell Biochem Funct; 2002 Jun; 20(2):177-81. PubMed ID: 11979514 [TBL] [Abstract][Full Text] [Related]
13. Comparative cytoprotective effect of dihydropyridine calcium channel blockers against the toxicity of oxidized low density lipoprotein for cultured lymphoid cells. Nègre-Salvayre A; Fitoussi G; Troly M; Salvayre R Biochem Pharmacol; 1992 Dec; 44(12):2379-86. PubMed ID: 1472103 [TBL] [Abstract][Full Text] [Related]
14. [Relation of Ca2+ efflux from the heart to the concentration of Ca-channel blockers]. Khmel'-Dunaĭ GN; Narushiavichus EV Biull Eksp Biol Med; 1985 Nov; 100(11):559-61. PubMed ID: 4063502 [TBL] [Abstract][Full Text] [Related]
15. Effect of anabasine on catecholamine secretion from the perfused rat adrenal medulla. Hong SP; Jeong MG; Lim DY J Cardiol; 2007 Dec; 50(6):351-62. PubMed ID: 18186309 [TBL] [Abstract][Full Text] [Related]
16. The interference of T cell activation by calcium channel blocking agents. Birx DL; Berger M; Fleisher TA J Immunol; 1984 Dec; 133(6):2904-9. PubMed ID: 6092460 [TBL] [Abstract][Full Text] [Related]
17. Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors. Thayer SA; Welcome M; Chhabra A; Fairhurst AS Biochem Pharmacol; 1985 Jan; 34(2):175-80. PubMed ID: 2981533 [TBL] [Abstract][Full Text] [Related]
19. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists. Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282 [TBL] [Abstract][Full Text] [Related]
20. Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes. Furukawa T; Nukada T; Namiki Y; Miyashita Y; Hatsuno K; Ueno Y; Yamakawa T; Isshiki T Eur J Pharmacol; 2009 Jun; 613(1-3):100-7. PubMed ID: 19401195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]